make it more attractive to a larger U.S. corporate tax inversion, which Emerson Electric attempted in 2016, however the change in the U.S. tax-code (see above), meant that Emmerson decided to abandon the inversion, and instead purchased a division of called Pentair Valves for $3.15 billion; the renaming Pentair group re-domiciled to the UK in 2018. , outside of U.S. and UK inversions to Ireland, there have been no other recorded corporate tax inversions to Ireland from other jurisdictions. Corporate tax haven Ireland as a tax haven Ireland is labelled both a corporate tax haven, due to its BEPS tools (e.g. Double Irish, Single Malt and CAIA), and a traditional tax haven, due to QIAIFs. The topic is covered in more detail in Ireland as a tax haven, however, the main facts regarding Ireland's corporate tax haven status are: Ireland does not appear on the 2017 OECD list of tax havens; only Trinidad and Tobago is on the 2017 OECD list, and no OECD member has ever been listed. Ireland does not appear on the 2017 EU list of 17 tax havens, or the EU's list of 47 "greylist" tax havens; again, no EU-28 country has ever been listed by the EU. Countermeasures to Ireland UK countermeasures (2009–2012) In September 2008, The New York Times reported that "Britain is facing a potential new problem: an exodus of British companies fleeing the tax system". During 2007–2008, several major UK multinationals executed corporate tax inversions to Ireland. During 2009–2012, both the Labour Government and the Conservative Government, overhauled the UK corporate tax code, switching from a "worldwide tax" system to a "territorial tax" system. By 2014, the UK HMRC reported most of the UK firms that inverted to Ireland had returned to the UK (e.g., WPP plc, United Business Media plc, Henderson plc), or were about to be acquired by U.S. multinationals as part of a U.S. tax inversion (e.g. Shire plc). , since the UK overhauled its tax code, there have been no inversions of UK firms to Ireland; of the 3 main UK–controlled firms in Ireland (see Table 1): Shire plc – the UK pharmaceutical inverted to Ireland in 2009, but did not return to the UK post the 2009–2012 UK tax reforms due to acquisition interest by U.S. pharmaceutical firms attempting to use Shire plc to execute a U.S. tax inversion to Ireland; however, the Obama administration's changes to